Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 6:24 pm Purchase | 2026-03-31 | 13G | DEXCOM, INC DXCM | Vanguard Capital Management | 28,848,218 7.490% | 28,848,218 (New Position) | Filing History |
| 2026-04-29 12:51 pm Purchase | 2026-03-31 | 13G | DEXCOM, INC DXCM | Vanguard Portfolio Management | 19,322,566 5.020% | 19,322,566 (New Position) | Filing History |
| 2026-03-26 6:02 pm Sale | 2026-03-13 | 13G | DEXCOM, INC DXCM | The Vanguard Group | 0 0.000% | -49,455,578 (Position Closed) | Filing History |
| 2025-10-30 2:56 pm Purchase | 2025-09-30 | 13G | DEXCOM, INC DXCM | The Vanguard Group | 49,455,578 12.610% | 4,988,427 (+11.22%) | Filing History |
| 2025-04-24 09:20 am Sale | 2025-03-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 32,504,140 8.300% | -7,946,917 (-19.65%) | Filing History |
| 2024-12-06 4:32 pm Purchase | 2024-11-30 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 40,451,057 10.400% | 7,599,584 (+23.13%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DEXCOM, INC DXCM | The Vanguard Group | 44,467,151 11.510% | 647,315 (+1.48%) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 32,851,473 8.500% | -684,207 (-2.04%) | Filing History |
| 2023-02-10 4:22 pm Sale | 2022-12-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 33,535,680 8.700% | -347,000 (-1.02%) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | DEXCOM, INC DXCM | The Vanguard Group | 43,819,836 11.340% | 2,178,560 (+5.23%) | Filing History |
| 2023-01-27 2:36 pm Unchanged | 2022-12-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 33,882,680 8.700% | 0 (Unchanged) | Filing History |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 33,882,680 8.800% | 1,368,864 (+4.21%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | DEXCOM, INC DXCM | The Vanguard Group | 41,641,276 10.740% | 712,296 (+1.74%) | Filing History |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | DEXCOM, INC DXCM | FMR LLC | 18,464,700 4.759% | -9,778,712 (-34.62%) | Filing History |
| 2022-02-08 5:12 pm Purchase | 2021-12-31 | 13G | DEXCOM, INC DXCM | BlackRock, Inc. BLK | 32,513,816 8.400% | 4,480,524 (+15.98%) | Filing History |
| 2021-12-06 09:35 am Sale | 2021-11-30 | 13G | DEXCOM, INC DXCM | BAILLIE GIFFORD & CO | 18,801,520 4.850% | -3,013,856 (-13.82%) | Filing History |